[ad_1]
Spirit Airlines’ stock slipped Thursday, after the discount air carrier reported a wider-than-expected second-quarter loss, while also detailing some cost cutting measures including pilot furloughs and capacity cuts.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...